Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients
Author:
Open Access
- 12 June 2012
- journal article
- research article
- Published by Wiley in Thrombosis
- Vol. 2012, 1-4
Abstract
Aim. Lebanon exhibits one of the highest prevalences of factor V-Leiden (FVL) in the world (14.4%). The aim of this study is to evaluate the incidence of FVL mutation among Lebanese patients with lower extremity venous thrombosis.Material and Methods. From January 2003 to January 2011, 283 consecutive Lebanese patients, diagnosed with deep venous thrombosis (DVT) by duplex scan, were retrospectively reviewed. FVL mutation was tested among patients with conditions highly suggestive of hypercoagulation states (65 patients).Results. FVL mutation was detected among 56.9% of patients, 68.6% of patients younger than 50 years, and 43.4% of patients older than 50 years (). FVL mutation was commonly reported in young adults, in patients with pregnancy, estrogen drugs, recurrent DVT, and resistance to anticoagulation.Conclusion. The high rate of FVL mutation observed among Lebanese patients with venous thrombosis is related to the high prevalence of this mutation in the Lebanese population. Thrombophilia screening should be tailored to accommodate a population's risk factor. In countries with high prevalence of FVL, this mutation should be screened among patients younger than 50 years and patients with situations highly suggestive of hypercoagulation states.Keywords
This publication has 38 references indexed in Scilit:
- Hereditary thrombophilia in an unselected cohort of venous thrombosis patients in SingaporeJournal of Clinical Pathology, 2011
- Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trialAnnals of Oncology, 2009
- Venous thromboembolism and ethnicityBritish Journal of Haematology, 2009
- Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registryThrombosis Research, 2009
- Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA studyJournal of Thrombosis and Haemostasis, 2008
- Cancer and thromboembolic disease: how important is the risk of thrombosis?Cancer Treatment Reviews, 2002
- Risk of recurrent venous thrombosis in children with combined prothrombotic risk factorsBlood, 2001
- The prevalence of factor V R506Q mutation-Leiden among apparently healthy LebaneseAmerican Journal of Hematology, 2000
- Epidemiology of Factor V Leiden: Clinical ImplicationsSeminars in Thrombosis and Hemostasis, 1998
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994